lumryz
(sodium oxybate)Avadel CNS Pharmaceuticals, LLC
Usage: LUMRYZ is indicated for treating cataplexy or excessive daytime sleepiness (EDS) in patients aged 7 and older with narcolepsy.
3 results
sunosi
(solriamfetol)Axsome Therapeutics, Inc.Usage: SUNOSI is indicated for improving wakefulness in adults with excessive daytime sleepiness due to narcolepsy or obstructive sleep apnea (OSA). It is not a treatment for the underlying airway obstruction in OSA; those treatments must continue during SUNOSI use.xyrem
(sodium oxybate)Jazz Pharmaceuticals, Inc.Usage: Xyrem is indicated for treating cataplexy and excessive daytime sleepiness in patients aged 7 and older diagnosed with narcolepsy.